Ribonucleases (RNases) are a diverse class of hydrolytic enzymes that catalyze the cleavage of phosphodiester bonds in RNA. They are broadly classified as endoribonucleases, which cleave internal phosphodiester bonds within RNA strands, and exoribonucleases, which remove nucleotides from RNA termini. RNases play essential roles in RNA metabolism, turnover, and processing, and are widely employed as laboratory tools for the removal of RNA contamination from DNA preparations, plasmid purification, and RNA structure–function studies. The most commonly used RNase, bovine pancreatic ribonuclease A (RNase A), has historically been purified from bovine pancreas—a tissue that contains approximately 1 mg of RNase A per gram and is also a rich source of other enzymes. This animal-derived origin introduces risks of viral and prion contamination, batch-to-batch variability, and the potential introduction of animal-derived contaminants into sensitive workflows.
Animal-free ribonucleases are recombinant enzymes that are both produced in non-animal expression systems and manufactured without the use of any animal-derived reagents or components at any stage of the production process. These reagents eliminate the risks associated with bovine-sourced enzymes while providing defined sequence, superior purity, and regulatory compliance suitable for advanced biopharmaceutical applications.
Rationale for Animal-Free Production
The shift toward animal-free RNase production is driven by several critical factors. The use of bovine RNase A is not without complication, and regulatory concerns regarding animal-derived materials have intensified. The substitution of bovine RNase A with recombinant RNase A is one option, addressing the need to avoid animal-sourced enzymes in the preparation of plasmid DNA for gene therapy or gene immunization. Animal-free RNases are produced without animal-derived components, thereby reducing the risk of potential introduction of animal-derived contaminants. Using animal origin-free enzymes avoids potential BSE/TSE and mammalian viral risks and regulatory issues associated with bovine and other animal sources.
A further advantage of recombinant RNase production is the reduction of contaminating activities. Bovine pancreas is a rich source of multiple enzymes, and RNase A purified from this tissue may carry residual DNase or protease activity. Recombinant RNases are expressed and extensively purified from non-animal hosts, yielding enzymes that are free of DNase and protease activity and suitable for sensitive molecular biology applications.